INS and Insulin resistance: In the population of all women and men with DM2 in ANCHOR, there were no significant increases in fasting plasma glucose, hemoglobin A1C, insulin, or homeostasis model assessment–estimated insulin resistance (HOMA-IR) following treatment with icosapent ethyl 4 g/day.21